William D. Turner - 04 Feb 2026 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role: Chief Regulatory Officer
Signature: /s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol: VERA
Transactions as of: 04 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Feb 2026, 20:00:09 UTC
Previous filing: 17 Dec 2025
Next filing: 25 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Turner William D.	Chief Regulatory Officer	C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE	/s/ Joseph R. Young, Attorney-in-Fact	06 Feb 2026	0001819688

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VERA	Class A Common Stock	Award	$0	+25,000	+111%	$0.000000	47,500	04 Feb 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERA	Stock Option (right to buy)	Award	$0	+50,000		$0.000000	50,000	04 Feb 2026	Class A Common Stock	50,000	$42.74	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date.
F2	1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.